Q3C Impurities: Residual Solvents_2011
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 24, 1997
April 8, 2020
b949f32c-660b-4c85-9e90-3fc9286ced2a
Related Documents
E2BM Data Elements for Transmission Of Individual Case Safety Reports
Guidance DocumentApril 4, 2002Center for Drug Evaluation and Research
Q1D Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products
Guidance DocumentJanuary 16, 2003Center for Drug Evaluation and Research
E9 Statistical Principles for Clinical Trials
Guidance DocumentSeptember 16, 1998Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox